Hansa Biopharma Hosts Virtual Event on Transplant Surgery and Im lifidase Phase 3 Results
Hansa Biopharma AB will host a virtual event featuring distinguished transplant surgeons to discuss clinical practice and imlifidase Phase 3 results.
The event will feature Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical College of Wisconsin.
- Event date: Wednesday, November 12, 2025
- Event time: 9:00 AM EST / 15:00 PM CET
The virtual event aims to provide deeper insights into the medical journey of highly sensitized patients awaiting a kidney transplant and share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.
Author summary: Hansa Biopharma hosts virtual event on transplant surgery insights.
More News
- What's on the ballot in the first general election since Donald Trump became president
- BLSA warns Operation Vulindlela implementation momentum is slowing | The Citizen
- Toronto Tempo Wins the Sandy Brondello Sweepstakes
- Pike man arrested for breaking into home, threatening woman - Mountain Top Media
- Salami’s pound of flesh? - The Nation Newspaper
- Vandalism: FCT NSCDC to prosecute offenders according to stringent laws - The Nation Newspaper
- Canada's immigration system is lost in the bushes
- The Home Depot Names Growscape Its 2025 Outdoor Garden Partner of the Year
- Mexican Authorities Suspect That Mayor Was Killed By The Jalisco Cartel: Report
- 10 Races to Watch This Election Day